HIV-1 TAT ALTERS NORMAL ORGANIZATION OF NEURONS AND ASTROCYTES IN PRIMARY RODENT BRAIN-CELL CULTURES - RGD SEQUENCE DEPENDENCE

被引:64
作者
KOLSON, DL
BUCHHALTER, J
COLLMAN, R
HELLMIG, B
FARRELL, CF
DEBOUCK, C
GONZALEZSCARANO, F
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,DEPT PROT BIOCHEM,KING OF PRUSSIA,PA 19406
[2] UNIV PENN,MED CTR,DEPT MICROBIOL,PHILADELPHIA,PA 19104
[3] UNIV PENN,DEPT PEDIAT,PHILADELPHIA,PA 19104
[4] UNIV PENN,DEPT MED,DIV PULM & CRIT CARE,PHILADELPHIA,PA 19104
[5] SMITHKLINE BEECHAM PHARMACEUT,DEPT MOLEC GENET,KING OF PRUSSIA,PA 19406
关键词
D O I
10.1089/aid.1993.9.677
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The HIV-1 trans-activator protein Tat has been implicated as a mediator of neuronal dysfunction in several model systems. To explore the possibility that Tat can affect primary brain cells, we examined the effect of recombinant Tat protein on rat cortical brain cell cultures. Tat induced marked aggregation of neurons and astrocytes in developing cultures and caused the neuritic processes to coalesce into fascicles. Cell death was not seen and brain macrophages were not affected. These effects mapped to a different region from the trans-activation domain of Tat, as mutating the RGD (arginine-glycine-aspartic acid) sequence within the second exon abrogated aggregation and fascicle formation without affecting trans-activation capacity. Such effects on primary neurons and astrocytes may reflect specific interactions of Tat with uninfected cells within the CNS in vivo.
引用
收藏
页码:677 / 685
页数:9
相关论文
共 55 条
[1]   Immunopathogenesis of HIV Encephalitis [J].
Achim, Cristian L. ;
Schrier, Rachel D. ;
Wiley, Clayton A. .
BRAIN PATHOLOGY, 1991, 1 (03) :177-184
[2]   INTEGRINS AND OTHER CELL-ADHESION MOLECULES [J].
ALBELDA, SM ;
BUCK, CA .
FASEB JOURNAL, 1990, 4 (11) :2868-2880
[3]   SYNTHESIS OF THE COMPLETE TRANSACTIVATION GENE-PRODUCT OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-III IN ESCHERICHIA-COLI - DEMONSTRATION OF IMMUNOGENICITY INVIVO AND EXPRESSION INVITRO [J].
ALDOVINI, A ;
DEBOUCK, C ;
FEINBERG, MB ;
ROSENBERG, M ;
ARYA, SK ;
WONGSTAAL, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (18) :6672-6676
[4]  
BANKER G, 1991, CULTURING NERVE CELL, P75
[5]  
BEIDLER JL, 1973, CANCER RES, V33, P2643
[6]   NO DIRECT NEURONOTOXICITY BY HIV-1 VIRIONS OR CULTURE FLUIDS FROM HIV-1-INFECTED T-CELLS OR MONOCYTES [J].
BERNTON, EW ;
BRYANT, HU ;
DECOSTER, MA ;
ORENSTEIN, JM ;
RIBAS, JL ;
MELTZER, MS ;
GENDELMAN, HE .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (04) :495-503
[7]   BIOLOGICALLY-ACTIVE SYNTHETIC PEPTIDES AS PROBES OF EMBRYONIC-DEVELOPMENT - A COMPETITIVE PEPTIDE INHIBITOR OF FIBRONECTIN FUNCTION INHIBITS GASTRULATION IN AMPHIBIAN EMBRYOS AND NEURAL CREST CELL-MIGRATION IN AVIAN EMBRYOS [J].
BOUCAUT, JC ;
DARRIBERE, T ;
POOLE, TJ ;
AOYAMA, H ;
YAMADA, KM ;
THIERY, JP .
JOURNAL OF CELL BIOLOGY, 1984, 99 (05) :1822-1830
[8]  
BRAKE D, 1990, J VIROL, V564, P962
[9]   IDENTIFICATION OF AN ARG-GLY-ASP (RGD) CELL-ADHESION SITE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSACTIVATION PROTEIN, TAT [J].
BRAKE, DA ;
DEBOUCK, C ;
BIESECKER, G .
JOURNAL OF CELL BIOLOGY, 1990, 111 (03) :1275-1281
[10]   AN ANTIBODY TO A RECEPTOR FOR FIBRONECTIN AND LAMININ PERTURBS CRANIAL NEURAL CREST DEVELOPMENT INVIVO [J].
BRONNERFRASER, M .
DEVELOPMENTAL BIOLOGY, 1986, 117 (02) :528-536